Ogtt test

Reading File
Finding Sources
Finding Sources
Let me pull the main Tietz section on OGTT and the diagnostic criteria table for full detail.
Reading File
Reading File
Reading File
Finding Sources

Quick answer

Oral Glucose Tolerance Test (OGTT)

Purpose: Serial measurement of plasma glucose before and after a standardized oral glucose load, used to diagnose diabetes mellitus, prediabetes (impaired glucose tolerance), and gestational diabetes. It is more sensitive than fasting plasma glucose (FPG) alone but has poorer reproducibility.

How it's done

  • Patient preparation: unrestricted diet with at least 150 g carbohydrate/day for 3 days beforehand, normal activity, then a 10-16 hour fast.
  • Test performed in the morning (7-9 am), patient seated, ambulatory (not on bed rest, not acutely ill/hospitalized), no smoking during the test.
  • Discontinue medications that affect glucose tolerance beforehand if possible (thiazides, corticosteroids, oral contraceptives, etc.).
  • Fasting venous plasma glucose is drawn first.
  • Glucose load: 75 g anhydrous glucose dissolved in water for non-pregnant adults (WHO standard); for children, 1.75 g/kg up to a 75 g max.
  • Venous plasma glucose measured fasting and again at 2 hours post-load (standard diagnostic OGTT). For gestational diabetes, a 100 g, 3-hour test with measurements at fasting, 1, 2, and 3 hours is often used.

Diagnostic interpretation (ADA criteria, non-pregnant adults)

  • Fasting: ≥126 mg/dL = diabetes
  • 2-hour post-75g load:
    • <140 mg/dL = normal
    • 140-199 mg/dL = impaired glucose tolerance (prediabetes)
    • ≥200 mg/dL = diabetes

Limitations

  • About 20% of OGTTs are "nondiagnostic" (only one abnormal sample).
  • Poor reproducibility due to many confounders: posture, anxiety, caffeine, smoking, activity, illness, age, prior carbohydrate intake, medications, sample handling.
  • Many guidelines recommend repeating on a separate day unless grossly abnormal.
  • Should use NGSP-certified lab methods, not point-of-care glucometers, for diagnosis.

Gestational diabetes

Diagnosed via either a one-step (75 g, 2-hr) or two-step (50 g screen, then 100 g, 3-hr diagnostic) OGTT approach, per obstetric guidelines.
Sources:
  • Tietz Textbook of Laboratory Medicine, 7th Edition
  • Goldman-Cecil Medicine, International Edition
Let me know if you want the specific gestational diabetes cutoffs (Carpenter-Coustan or NDDG criteria) or a comparison with HbA1c/FPG.
Reading File
Now I have comprehensive detail. Let me quickly check for recent guideline updates via PubMed for currency.
Searching PubMed

"oral glucose tolerance test" diagnosis diabetes

These don't change the core diagnostic criteria; they're peripheral (screening comparisons, insulinoma, PCOS). No conflict with textbook info. Here's the full answer.

Oral Glucose Tolerance Test (OGTT)

What it is

The OGTT measures how the body clears a glucose load from the blood over time. It is more sensitive than fasting plasma glucose (FPG) alone for detecting glucose intolerance, though it has poorer reproducibility - about 20% of OGTTs are "nondiagnostic" (only one abnormal reading), so some guidelines recommend repeating the test on a separate day before confirming diabetes (Tietz Textbook of Laboratory Medicine, p. 1731-1732).

Standard protocol (non-pregnant adults)

  • Preparation: unrestricted diet with at least 150 g carbohydrate/day and normal activity for 3 days beforehand; discontinue drugs known to affect glucose tolerance if possible.
  • Fast: 10-16 hours overnight, ambulatory (not bedridden/hospitalized/acutely ill patients).
  • Timing: test starts between 7-9 am; patient remains seated, no smoking.
  • Glucose load: 75 g anhydrous glucose in water for adults (children: 1.75 g/kg up to 75 g max).
  • Sampling: venous plasma glucose measured fasting and at 2 hours post-load.

Diagnostic criteria (ADA, any one of the following is diagnostic)

  1. HbA1c ≥ 6.5% (≥48 mmol/mol)
  2. FPG ≥ 126 mg/dL (≥7.0 mmol/L)
  3. 2-hour plasma glucose ≥ 200 mg/dL (≥11.1 mmol/L) during OGTT
  4. Random plasma glucose ≥ 200 mg/dL with classic hyperglycemic symptoms/crisis
In the absence of unequivocal hyperglycemia, two abnormal results (same or separate samples) are required. Interpretation bands for the 2-hour OGTT value:
  • Normal: <140 mg/dL (<7.8 mmol/L)
  • Impaired glucose tolerance (prediabetes): 140-199 mg/dL (7.8-11.0 mmol/L)
  • Diabetes: ≥200 mg/dL (≥11.1 mmol/L)
(Tietz Textbook of Laboratory Medicine, p. 1731-1732)

Factors that can distort results (non-diabetic influences)

  • Patient prep: fasting duration, prior carbohydrate intake, medications (thiazides, oral contraceptives, corticosteroids), trauma, intercurrent illness, age, activity level, weight
  • During the test: posture, anxiety, caffeine, smoking, activity, time of day, sample handling
  • Glucose administration: form (anhydrous vs. monohydrate) and quantity ingested (Box 47.4, Tietz Textbook of Laboratory Medicine)

Gestational diabetes variant

Two approaches are used:
  • Two-step approach: 1-hour, 50-g glucose challenge test first (screening); if the result exceeds threshold (≥135-140 mg/dL), proceed to a confirmatory 3-hour, 100-g OGTT.
  • Diagnostic thresholds for the 100-g/3-hour OGTT (ACOG, per Creasy & Resnik's Maternal-Fetal Medicine, p. gestational diabetes chapter):
TimepointThreshold
Fasting95 mg/dL (5.3 mmol/L)
1 hour180 mg/dL (10.0 mmol/L)
2 hour155 mg/dL (8.6 mmol/L)
3 hour140 mg/dL (7.8 mmol/L)
Two or more values meeting/exceeding these thresholds confirm gestational diabetes, though 2018 ACOG guidance notes that a single abnormal value may also be treated.

Other clinical uses

Beyond diabetes screening, the OGTT (with insulin/C-peptide sampling) is used in the workup of postprandial hyperinsulinemic hypoglycemia and insulinoma, acromegaly (failure of growth hormone suppression is diagnostic), and occasionally to help differentiate MODY from type 1/2 diabetes, though genetic testing is required for a definitive MODY diagnosis.
Recent systematic reviews (2024-2025) have looked at OGTT accuracy in specific populations - e.g., comparing risk-score screening tools against OGTT, and evaluating OGTT/FPG/HbA1c accuracy in women with PCOS - but none of these change the standard diagnostic thresholds above; they mainly address screening strategy and population-specific test performance (PMIDs: 40947023, 38442646).
This is a shared conversation. Sign in to Orris to start your own chat.